The Personalisation of Glioblastoma Treatment Using Whole Exome Sequencing: A Pilot Study

The molecular heterogeneity of glioblastoma has been linked to differences in survival and treatment response, while the development of personalised treatments may be a novel way of combatting this disease. Here we show for the first time that low passage number cells derived from primary tumours ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrett, Anne-Marie, Lastakchi, Sarah, McConville, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074406/
https://www.ncbi.nlm.nih.gov/pubmed/32041307
http://dx.doi.org/10.3390/genes11020173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074406/
https://www.ncbi.nlm.nih.gov/pubmed/32041307
http://dx.doi.org/10.3390/genes11020173

Ejemplares similares